Rapamycin was a widely-discussed drug since it derived in 1972 from Sirolimus bacterium. Initially, it was used by the physicians to treat fungal conditions due to its anti-fungal properties. But in the later years, many researchers have started focusing on the healing effects of rapamycin and identified more areas where it could be used as an ideal drug. Dr. Mikhail Blagosklonny was the most prominent researcher who tried to unwind the secrets of rapamycin. He identified numerous benefits of the drug and stated that it shows immunosuppressant properties. It means that the drug can be used effectively to prevent the possibilities of rejection of organs during an organ transplant.
To add on that, Dr. Blagosklonny confirms how it could be used while treating the emolytic-uremic syndrome. The disease is a condition of low platelet count, kidney failure, and anemia. After making a kidney transplant, the new organ has a very high susceptibility to the same disease. Rapamycin can be used as a drug in treating the post-transplant condition as it reduces toxicity levels at kidneys. It is the primary drug in treating a rare lung condition called Lymphangioleiomyomatosis – a disease that affects women during childbearing age. Dr. Blagosklonny confirms that the drug is effective in treating cancer when administered in the right doses. He says that the medicine has the ability to increase the immunity of the human body to fight against tumors.
Dr. Blagosklonny further adds that it can also be used as a preventive medicine due to its regressive character against cancer. It is also effective in treating TSC or Tuberous Sclerosis Complex. It is a congenital disorder that creates benign tumor in heart, brain, kidney, and other organs. Researches have verified that mTOR inhibitors by rapamycin can suppress TSC successfully. Dr. Blagosklonny conducted extensive research and found that rapamycin could create in the longevity of human beings. He proved that the proper administration of the drug could help people to increase their lifespan and improve their health as well. His experiments with mice have delivered excellent results in terms of longevity of life, and he is on his way for further research. Dr. Blagosklonny is also in the research to prove that the drug can heal Alzheimer’s disease, Muscular Dystrophy, and Systemic Lupus Erythematosus.
Dr. Mikhail Blagosklonny is currently working as a researcher and professor at the Rosewell Park Cancer Institute located in New York City. He has a philanthropic mind and dreams that people across the world should have access to more effective treatment solutions than of current times, irrespective of their financial background. Dr. Blagosklonny focuses on both anti-aging research and oncology considering both are highly important considering the multiple aging diseases and millions of cancer patients.
While coming to cancer research, Dr. Blagosklonny thinks that it is his duty to design a treatment procedure that helps cancer patients to destroy affected cells without causing any harm to healthy cells. It is widely accepted that such a treatment plan would ensure quicker recovery for cancer patients after the treatment. Dr. Blagosklonny also works with many medical journals in their editorial roles.